Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 7 filers reported holding Novozymes A/S in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,460 | -11.8% | 285 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $13,000 | -7.1% | 285 | +4.4% | 0.00% | 0.0% |
| Q1 2023 | $14,000 | +1.6% | 273 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $13,776 | -1.6% | 273 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $14,000 | -12.5% | 273 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $16,000 | +6.7% | 273 | +23.0% | 0.00% | – |
| Q1 2022 | $15,000 | -74.6% | 222 | -69.3% | 0.00% | -100.0% |
| Q4 2021 | $59,000 | +18.0% | 723 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $50,000 | -9.1% | 723 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $55,000 | +19.6% | 723 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $46,000 | +12.2% | 723 | +1.1% | 0.00% | 0.0% |
| Q4 2020 | $41,000 | -8.9% | 715 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $45,000 | +275.0% | 715 | +234.1% | 0.00% | – |
| Q2 2020 | $12,000 | +33.3% | 214 | +4.9% | 0.00% | – |
| Q1 2020 | $9,000 | +28.6% | 204 | +40.7% | 0.00% | – |
| Q4 2019 | $7,000 | – | 145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lenox Wealth Management, Inc. | 62,488 | $2,907,000 | 0.87% |
| ZEVIN ASSET MANAGEMENT LLC | 34,899 | $1,624,000 | 0.52% |
| HIGH POINTE CAPITAL MANAGEMENT LLC | 5,090 | $238,000 | 0.33% |
| BOSTON FINANCIAL MANGEMENT LLC | 108,846 | $5,065,000 | 0.29% |
| Moloney Securities Asset Management, LLC | 15,263 | $713,000 | 0.24% |
| Boston Common Asset Management, LLC | 24,577 | $1,148,000 | 0.14% |
| Hemenway Trust Co LLC | 12,125 | $564,000 | 0.09% |
| Renaissance Investment Group LLC | 5,000 | $234,000 | 0.09% |
| QUADRANT CAPITAL GROUP LLC | 5,748 | $263,000 | 0.04% |
| Douglass Winthrop Advisors, LLC | 6,902 | $321,000 | 0.01% |